A global phase 3 trial of HMI-115 in patients with Endometriosis
Latest Information Update: 29 Oct 2024
At a glance
- Drugs BAY 1158061 (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- Sponsors Hope Medicine
- 29 Oct 2024 New trial record
- 24 Oct 2024 According to a Hope medicine media release, company plans to initiate global phase III trial in Endometriosis.